1994
DOI: 10.1111/j.1365-2249.1994.tb06236.x
|View full text |Cite
|
Sign up to set email alerts
|

Oral and aerosol immunization with viable or inactivatedActinobacillus pleuropneumoniaebacteria: antibody response to capsular polysaccharides in bronchoalveolar lavage fluids (BALF) and sera of pigs

Abstract: SUMMARYTo investigate the aniibody response after local application of lung-pathogenic bacteria, pigs were immunized with viable or inactivated Actinohacillus pteuropneumomae by the oral and aerogcnous route. Afler 3 weeks class-specific immunoglobulins againsl purified A. pleuropneumoniae capsular polysaccharides (CP) were determined in scrum and BALF by ELISA. A significant increase of IgA antibodies was found in BALF but nol in sera of all iminuni7x;d pigs. Oral immunizalion with viable A. pteuropncurnoriic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1995
1995
2020
2020

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 18 publications
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…Therefore, we recommend the term i MALT: Integrated mucosal lymphoid tissue (Pabst and Brandtzaeg 2020), because there is preferential migration of lymphoid cells, e.g., from the gut wall to the bronchial tract. An example is to protect pigs from the bacterial lung infection by Actinobacillus pleuropneumoniae by giving an oral dose of encapsulated bacteria (Hensel et al 1994;Hensel et al 1996). A surprising finding was a dramatic increase of plasma cells in the bronchiolar lavage (Delventhal et al 1992).…”
Section: Mucosal Immunologymentioning
confidence: 99%
“…Therefore, we recommend the term i MALT: Integrated mucosal lymphoid tissue (Pabst and Brandtzaeg 2020), because there is preferential migration of lymphoid cells, e.g., from the gut wall to the bronchial tract. An example is to protect pigs from the bacterial lung infection by Actinobacillus pleuropneumoniae by giving an oral dose of encapsulated bacteria (Hensel et al 1994;Hensel et al 1996). A surprising finding was a dramatic increase of plasma cells in the bronchiolar lavage (Delventhal et al 1992).…”
Section: Mucosal Immunologymentioning
confidence: 99%